As of August 2026, 490 paid clinical trials are recruiting in Fairfax, Virginia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fairfax offers studies at sites including NEXT Virginia for conditions such as Advanced Solid Tumor, Ovarian Cancer, Endometrial Cancer, Advanced Solid Tumors. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Fairfax, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| NEXT Virginia | Advanced Solid Tumor, Advanced Solid Tumors, Solid Tumor | 72 |
| Virginia Cancer Specialists | Breast Cancer, Endometrial Cancer, Ovarian Cancer | 64 |
| Inova Schar Cancer Institute | Breast Cancer, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | 55 |
| NEXT Oncology Virginia | Colorectal Cancer, Advanced Solid Tumors, Cancer | 29 |
| NEXT Oncology | Solid Tumor, Ovarian Cancer, Breast Cancer | 25 |
| Virginia Cancer Specialists, PC | Breast Cancer, Esophageal Adenocarcinoma, Metastatic Breast Cancer | 15 |
| Inova Fair Oaks Hospital | Ovarian Carcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 | 13 |
| Re:Cognition Health | Alcohol Use Disorder, Alzheimers Disease, Amyloid | 7 |
| Inova Fairfax Hospital | Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Cardiovascular Diseases | 6 |
| Inova Schar Cancer | Advanced Or Metastatic Merkel Cell Carcinoma, Colorectal Cancer, EGFR Inhibitor-associated Rash | 6 |
| NEXT Oncology - Virginia | Advanced Solid Tumors, CNS Tumor, Cholangiocarcinoma | 4 |
| NEXT Oncology - Virginia Cancer Specialists | Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, CNS Metastases | 4 |
| O & O Alpan | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 4 |
| Virginia Cancer Specialists PC | Anaplastic Lymphoma Kinase (ALK) Positive, Extensive Stage Small-cell Lung Cancer, Metastatic Castration-resistant Prostate Cancer | 4 |
| Zai Lab | Sarcomas, Small-cell Lung Cancer, Solid Tumors | 4 |
| Dren Investigational Site | Aggressive NK Cell Leukemia, Aplastic Anemias, Bone Marrow Failure Syndromes | 3 |
| George Mason University | Hiv, Major Depressive Disorder (MDD), Mental Health Issue | 3 |
| Inova Health Care Services | Angina, Calcium Release Deficiency Syndrome, Femoral Neck Fractures | 3 |
| Inova Health System | Cervical Cancer, Coronary Artery Disease Progression, Coronary Artery Disease Risk Factors Multiple | 3 |
| Lysosomal Rare Disorders Research and Treatment Center | Niemann-Pick Type C Disease, GM1 Gangliosidosis, GM2 Gangliosidosis | 3 |
| Lysosomal and Rare Disorders Research and Treatment Center, Inc. | Fabry Disease, Pompe Disease | 3 |
| Nephrology Associates of Northern Virginia Inc | Antineutrophil Cytoplasmic Antibody-associated Vasculitis, End Stage Kidney Disease, Primary IgA Nephropathy | 3 |
| Avenzo Therapeutics Recruiting Site | Biliary Tract Cancer (BTC), Epithelial Tumor, HR+, HER2-, Advanced Breast Cancer | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| Clinical Trial Site | Advanced Solid Tumor, High Cardiovascular Risk, High Risk Cardiovascular Disease | 2 |
Recruiting trials in Fairfax grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 490 recruiting clinical trials in Fairfax, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Fairfax compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Fairfax include Advanced Solid Tumor (32), Ovarian Cancer (27), Endometrial Cancer (26), Advanced Solid Tumors (24), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fairfax on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Fairfax include NEXT Virginia, Virginia Cancer Specialists, Inova Schar Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Fairfax are Cancer & tumors (330), Cardiovascular (9), Neurology & pain (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.